Results 101 to 110 of about 3,671 (210)

Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors

, 2019
Objetivo: determinar os fatores clínicos e demográficos associados à remissão de doença e sobrevida de droga em pacientes com espondilite anquilosante (EA) em uso de antifator de necrose tumoral (anti-TNF).
Shimabuco, Andréa Yukie
core   +1 more source

Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging

Therapeutic Advances in Musculoskeletal Disease
Background: The efficacy and safety of bimekizumab (BKZ), an inhibitor of interleukin (IL)-17F in addition to IL-17A, has been established in axial spondyloarthritis (axSpA). Early assessment of new bone formation is possible using 18 F-fluoride positron
Xenofon Baraliakos, Jerney de Jongh, Denis Poddubnyy, Gerben J. C. Zwezerijnen, Robert Hemke, Sophie Glatt, Stevan Shaw, Lucian Ionescu, Assem el Baghdady, Joanne Mann, Ralph Paul Maguire, Tom Vaux, Natasha de Peyrecave, Marga Oortgiesen, Dominique Baeten, Conny van der Laken   +15 more
doaj   +1 more source

Foot pain and disability in patients with ankylosing spondylitis is associated to disease activity

BrJP
BACKGROUND AND OBJECTIVES: The feet may be involved in patients with ankylosing spondylitis (AS), causing pain and walking difficulties. This research aimed to study the involvement of the foot in a sample of Brazilian patients with AS.
Ohana Vasconcelos, Ynaray Brandão dos Santos, Renato Nisihara, Ana Beckhauser, Juliana Simioni, Thelma Skare   +5 more
doaj   +1 more source

Efficacy and safety of tofacitinib in ankylosing spondylitis patients: a systematic review and meta-analysis. [PDF]

Clinics (Sao Paulo)
Shen L, Han K, Bo L, Huang F.
europepmc   +1 more source

Efficacy and Safety Assessment of Upadacitinib for SAPHO Syndrome: A Retrospective Study of 35 Patients. [PDF]

Int J Rheum Dis
Meng F, Zhang Y, Chen Y, Lin Z, Li C, Hou X, Wu Y.   +6 more
europepmc   +1 more source

Relationship of Vitamin D, Spondyloarthritis Activity and Left Ventricular Systolic and Diastolic Function. [PDF]

J Clin Med
Miletić Gršković S, Uravić Bursać I, Tudor Špalj V, Drvar V, Sotošek V, Kehler T, Peršić V, Sinožić T, Laškarin G.   +8 more
europepmc   +1 more source

Impact of vitamin D levels on disease activity, function and health over 2 years in radiographic axial spondyloarthritis: data from GErman SPondyloarthritis Inception Cohort (GESPIC). [PDF]

RMD Open
Torgutalp M, Proft F, Haibel H, Baum H, D'Urso M, Höppner C, Protopopov M, Rademacher J, Sahin D, Poddubnyy D, Rios Rodriguez V.   +10 more
europepmc   +1 more source

Impact of sex and HLA-B27 positivity on clinical characteristics and patient-reported outcomes in a cohort of Egyptian axial spondyloarthritis patients. [PDF]

BMC Musculoskelet Disord
Soliman E, Zeheiry M, Abu Halawa Y, Shaaban A.   +3 more
europepmc   +1 more source

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Objectives: In patients with axial spondyloarthritis (axSpA) initiating their first tumor necrosis factor alpha-inhibitor (TNFi), we aimed to identify common baseline predictors of Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP) inactive ...
Akkoc, N, Georgiadis, S, Horst-Bruinsma, IV, Relas, H, Corrado, A, Pavelka, K, Gunduz, OS, Linde, L, Závada, J, Santos, MJ, Tomsic, M, Santos, H, Rotar, Z, Iannone, F, Glintborg, B, Kristianslund, EK, Ornbjerg, LM, Pirilä, L, Laas, K, Michelsen, B, Lindström, U, Rasmussen, SH, Codreanu, C, Hetland, ML, Jones, GT, Gudbjornsson, B, Askling, J, Ciurea, A, Nissen, MJ, Di Giuseppe, D, Loft, AG, Geirsson, AJ, Ostergaard, M, Wallman, JK   +33 more
core  

Treatment Persistence and Factors Associated with Bimekizumab Discontinuation in Psoriatic Arthritis and Axial Spondyloarthritis: A Real-World Multicenter Study. [PDF]

Biomedicines
Pinto-Tasende JA, Garcia-Porrua C, Maceiras-Pan F, Melero-González RB, Hernandez Del Rio A, Cervantes Pérez EC, Quevedo-Vila V, Iñiguez CL, Alonso-Castro S, Caeiro-Aguado M, Queiro R.   +10 more
europepmc   +1 more source